Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 20 21 22 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Protembis–SEVERAL: investment, 201507 seed financing round 7-digit € incl Innovationsstarter Fonds + Geratherm + angel investors 2015-07-28
Leon-Nanodrugs–Albany Private Equity: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Albany Private Equity Holding 2015-07-27
Leon-Nanodrugs–CD-Venture: investment, 201507 financing round Series A 1st closing totalling €18.5m incl CD-Venture 2015-07-27
Leon-Nanodrugs–LifeCare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl LifeCare Partners 2015-07-27
Leon-Nanodrugs–MJR PharmJet: nanoparticle drug delivery technology, 201507 collab existent 2015-07-27
Leon-Nanodrugs–OTHER: investment, 201507 financing round Series A 1st closing totalling €18.5m incl non-disclosed German Family Office 2015-07-27
Leon-Nanodrugs–SEVERAL: investment, 201507 financing round Series A 1st closing €18.5m led by TVM Capital Life Science 2015-07-27
Leon-Nanodrugs–Signet Healthcare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Signet 2015-07-27
Leon-Nanodrugs–TVM: investment, 201507 financing round Series A 1st closing totalling €18.5m led by TVM Capital Life Science 2015-07-27
Merck (DE)–Celares: protein pegylation services, 201507– collab Merck Millipore offering PEG services tog with Celares GmbH 2015-07-27
Medigene–QVT: investment, 201507 QVT owns 15.6% of Medigene shares after capital increase 2015-07-25
Poxel–MacDougall Biomedical Communications: public relations, 201507 service existent IR + PR in EU + US 2015-07-24
Scienion–Anteo Technologies: protein microarray technology, 201507– collab developm protein microarray consumables using Mix&Go technology 2015-07-24
BeneChill–Odlander Fredrikson: investment, 201507 existent investment listed on HealthCap web site 2015-07-23
Merck (DE)–BioMed X: pharma research, 201507– collab Merck Serono extension funding two cancer research groups at BioMed X 2015-07-23
Cevec–SEVERAL: investment, 201507 financing round €4.5m from Peppermint + Creathor Venture + NRW.Bank + Investtodate et al 2015-07-22
Leukocare–LifeCare Partners: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors 2015-07-22
Leukocare–SEVERAL: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors 2015-07-22
Memo Therapeutics–SEVERAL: investment, 201507 financing round Series A CHF2.3m from Swiss investors incl EVA Basel + Redalpine + Zürcher Kantonalbank 2015-07-22
Merck (DE)–Genedata: bioinformatics, 201507– supply Merck Serono implements Genedata Biologics as workflow platform for biopharma RnD 2015-07-22
Allergan–Molecular Partners: ophthalmics, 201507– collab expansion of DARPin alliance in ophthalmology 2015-07-21
Anagnostics–Cube Dx: investment, 201507 acquisition of all assets of Anagnostics Bioanalysis GmbH by Cube Dx GmbH 2015-07-21
Medigene–Aviva: investment, 201507 acquisition 1.97m shares by Aviva plc representing 10.01% of Medigene shares after capital increase 2015-07-20
BioAnalytica GenoType–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Bioarray (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Cialab (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Genetadi Biotech–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Genycell–Sophia Genetics: bioinformatics, 201507– distribution of Sophia DDM platform for clinical NGS data analysis in Iberia by Genycell 2015-07-16
Immunocore–Credit Suisse: investment banking, 201507 supply service Credit Suisse is advisor on $320m Series A round 2015-07-16
Immunocore–Malin Corp: investment, 201507 financing round Series A totalling $320m (£205m) incl new investor Malin Corp plc 2015-07-16
Immunocore–SEVERAL: investment, 201507 financing round Series A $320m (£205m) private from new + existing investors 2015-07-16
Piqur Therapeutics–SEVERAL: investment, 201507 financing round Series A2 CHF18m incl returning investor Versant Ventures 2015-07-16
Piqur Therapeutics–Versant Ventures: investment, 201507 financing round Series A2 totalling CHF18m incl returning investor Versant Ventures 2015-07-16
Accurate Mass Scientific–CovalX: mass spectrometry, 201507– collab AMS new Australian distributor of CovalX High-Mass systems + CRO analytics services 2015-07-15
Canbridge Life Sciences–Apogenix: cancer drug, 201507– license developm + commercialisation of APG101 in Greater China 2015-07-15
Volution Immuno Pharmaceuticals–Celsus Therapeutics: investment, 201508– reverse merger acqu of VIP by Celsus to be renamed Akari Therapeutics 2015-07-13
Apceth–Univ Cologne: T-cell immunotherapy, 201507– collab with CMMC use of MSCs for local activation of CAR T-cells within tumours 2015-07-10
Insilico Biotechnology–SEVERAL: investment, 201507 capital increase 2015-07-10
SGS–Northern Exposure PR: public relations, 201507 service existent for SGS Life Sciences by NEPR 2015-07-10
JeNaCell–Evonik: investment, 201507 financing round Series A incl new investor Evonik Industries 2015-07-09
JeNaCell–High-Tech Gründerfonds: investment, 201507 financing round Series A incl existing investor HTGF 2015-07-09
JeNaCell–SEVERAL: investment, 201507 financing round Series A from Evonik + bm-t + Sparkasse Jena + HTGF + STIFT 2015-07-09
InSphero–HP Wild Holding: investment, 201507 Series C financing CHF20m from HP Wild Holding AG 2015-07-08
Qiagen–Seegene: molecular diagnostics, 201507– collab ww marketing validated multi-plexed Seegene PCR tests for QIAsymphony RGQ MDx system 2015-07-08
Cassiopea–Cosmo Pharmaceuticals: investment, 201507 existent 45.4% shareholder after spin-off of Cassiopea from Cosmo via IPO at SIX 2015-07-06
Cellca–Sartorius: investment, 201507 acquisition of Cellca GmbH by Sartorius Stedim Biotech 2015-07-02
Neovacs–MC Services: public relations, 201507 service existent by MC Services IR in Germany 2015-07-02
Actelion–Qlucore: bioinformatics, 201507– license 3y to Omics Explorer s/w after using it since 2011 2015-07-01
Biotest–Cevec: rec protein production technology, 201507– license to CAP Go technology to Biotest AG 2015-07-01
GNA Biosolutions–Instinctif Partners: public relations, 201507 service existent by Instinctif Partners 2015-07-01
GNA Biosoutions–SEVERAL: investment, 201507 financing round Series B €6m led by new investor Robert Bosch Venture Capital GmbH 2015-07-01
Seres Therapeutics–Nestlé: investment, 201507 equity investment by Nestlé Health Science 2015-07-01
TAmiRNA–EU (govt): grant, 201507– Horizon 2020 SME Instrument Phase I Funding for collab with IPF Vienna 2015-07-01
Spinifex Pharmaceuticals–Novartis: investment, 201506– acquisition €na ANNOUNCED 2015-06-29
Actelion–Max Planck: vaccine technology, 201506 license excl synthetic carbohydrate vaccines for new Vaxillion joint venture from + with Max Planck 2015-06-26
Qiagen–Zörgiebel Group: molecular diagnostics, 201506– collab founding joint venture Biotye Innovation GmbH to develop MDx companion diagnostics 2015-06-26
Vaxxilon–Actelion: investment, 201506 founding w Max Planck + Actelion as majority owner w committed funding of €30m over 4y in tranches 2015-06-26
BioNTech–Siemens: cancer vaccine, 201506– collab developm + construction automated production facility for IVAC products Siemens Process Automation 2015-06-25
BioNTech–Strüngmann Group: investment, 201506 existent Strüngman family office is majority shareholder of BioNTech AG 2015-06-25
Gladstone Institutes–Thermo Fisher: grant, 201506– sponsoring of new Thermo Fisher Proteomics Facility for Disease Target Discovery at Gladstone 2015-06-24
Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply Orbitrap Fusion Tribrid system to new Proteomics Facility at Gladstone 2015-06-24
Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply TSQ Quantiva Triple Quad LC/MS system to new Proteomics Facility at Gladstone 2015-06-24
Thermo Fisher–Gladstone Institutes: mass spectrometry, 201506– collab establ new Thermo Fisher Proteomics Facility at Gladstone in collab w UCSF + QB3 2015-06-24
Ankasa Regenerative–Avalon Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A led by Avalon Ventures 2015-06-23
Ankasa Regenerative–Correlation Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Correlation 2015-06-23
Ankasa Regenerative–Heraeus: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Heraeus Medical 2015-06-23
Ankasa Regenerative–SEVERAL: investment, 201506 financing round Series A 1st tranche $8.5m of planned $17m Series A led by Avalon Ventures 2015-06-23
ViraTherapeutics–Austria (govt): investment, 201506 financing round Series A 1st closing totalling €3.6m incl co-investor aws 2015-06-23
ViraTherapeutics–Boehringer: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
ViraTherapeutics–EMBL: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
ViraTherapeutics–SEVERAL: investment, 201506 financing round Series A 1st closing €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
4SC–SEVERAL: investment, 201506–201507 cash capital increase €29m (net €27.5m) with 7.25m new shares at €4/share 2015-06-22
4SC–Strüngmann Group: investment, 201506–201507 capital increase €6m in kind 1.5m new shares at €4/share swapping part of shareholder loan from Santo 2015-06-22
4SC–Wellington Partners: investment, 201506–201507 cash capital increase totalling €29m incl €5m from Wellington 2015-06-22
Univ California–Scienion: automated liquid handling, 201506 supply existent Gianneschi Group at UCSD is early user of sciTEM system 2015-06-22
ChemAxon–BSSN Software: cheminformatics, –201506 collab developm Mass Spec Add-on for Instant JChem using Seahorse Scientific Workbench s/w platform 2015-06-18
Pierre Fabre–Biomax: bioinformatics, 201506– license to BioXM Knowledge Management Environment + collab database development 2015-06-18
Qiagen–Hitachi: genomic testing systems, 201506– collab strategic alliance €na developm PCR + NGS based automation systems for research + IVD 2015-06-18
IntelliCyt–Genedata: drug screening software, 201506– collab product integration of Genedata Screener s/w with iQue Screener system 2015-06-17
Pierre Fabre–Affimed: antibody technology, 201506– collab expansion 3y €na use AbCheck’s AbSieve+AbAccel techn to discover ABs against targets of CIPF 2015-06-17
Affiris–MIG Fonds: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
Affiris–SEVERAL: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
Affiris–Strüngmann Group: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
Debiopharm–Spinomix: sample processing technology, 201506 acquisition €na of FibroTrap technology by Debiopharm International SA 2015-06-16
Stratos–Roche: investment, 201506 investment $10m in Stratos Genomics related to technical milestone in collab on SBX technology 2015-06-16
Medigene–BIO (US): trade fair, 201506 supply service Medigene participates in BIO 2015 2015-06-15
Roche–Almac: cancer drugs, 201506– collab $14.5m upfront + $349m milestones + royalties r+d small molecule inhibitors of USP target Genentech 2015-06-15
Medigene–SEVERAL: investment, 201506 capital increase €46.4m with 5.6m new shares at €8.3/share 2015-06-12
BioNTech–Stratifyer: molecular diagnostics, –201506 collab developm of RT-qPCR based MammaTyper test 2015-06-11
JnJ–Max Planck: drug discovery services, 201506– collab 2y of LDC with JnJ Innovation Centre London 2015-06-11
Bayer–Kohlberg Kravis Roberts: investment, 201506– acquisition €1.022b of Bayer Diabetes Care by Panasonic Healthcare Holdings owned 80% by KKR 2015-06-10
OmicScouts–Pelago Bioscience: drug discovery technology, 201506– license + collab developm €na CETSA method for mass spec-based proteomics 2015-06-10
OTHER–AMP Biosimilars: biopharmaceutical, 201506– license for biogeneric humanised MAb ABY-021 in China to mid-sized Chinese pharma company 2015-06-10
Alpha Laboratories–Eppendorf: gradient PCR technology, 201506 license to Patent EP1426110B1 to Alpha Laboratories Ltd 2015-06-09
Cassiopea–SEVERAL: investment, 201506–201507 IPO CHF175.6m at SIX w 4.8m+363.6k shares at CHF34/share sold by Cosmo 2015-06-09
QuantuMDx–Scienion: print/spotting technology, 201506 supply purchase sciFlexarrayer SX to transfer biological material on Q-POC biosensor 2015-06-09
Thermo Fisher–Eppendorf: gradient PCR technology, 201506 license to Patent EP1426110B1 to Life Technologies Corp 2015-06-09
BIA Separations–Labena: investment, 201506 acquisition of BIA Separation’s CRO laboratory by Labena 2015-06-08
Labena–BIA Separations: chromatography column, 201506– distribution of CIM columns by Labena in South Eastern Europe 2015-06-08
Qiagen–Inova HealthSystems: genome database, 201506– excl distribution of Inova Genomes whole-genome database of ITMI by Qiagen 2015-06-08
next pagenext page 1 2 3 ... 20 21 22 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top